MarketCap
Mesoblast Limited MESO
€ 12.74
-3.31%
Facebook
X
Telegram
Land |
 Australien |
IPO-Jahr |
2015 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
1.21 B |
Marktkapitalisierung |
$ 17.3 B |
EBITDA (LTM) |
- |
P/E (LTM) |
-184.869976 |
P/S (LTM) |
1098.376822 |
EPS (LTM) |
-0.0846 |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
PolyPid Ltd.
PYPD
|
$ 5.69 | 4.21 % | $ 93 M | Nasdaq Global Select Market |  Israel |
 |
Outlook Therapeutics
OTLK
|
$ 0.46 | -0.8 % | $ 16 M | Nasdaq Global Select Market |  USA |
 |
uniQure N.V.
QURE
|
$ 23.04 | -3.48 % | $ 1.32 B | Nasdaq Global Select Market |  Niderland |
 |
Ultragenyx Pharmaceutical
RARE
|
$ 17.14 | 3.07 % | $ 1.69 B | Nasdaq Global Select Market,SPB | USA |
 |
Regeneron Pharmaceuticals
REGN
|
$ 931.5 | -4.3 % | $ 97.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Rafael Holdings
RFL
|
$ 1.1 | 1.97 % | $ 56.5 M | NYSE | USA |
 |
REGENXBIO
RGNX
|
$ 7.61 | -0.33 % | $ 392 M | Nasdaq Global Select Market,SPB | USA |
 |
China SXT Pharmaceuticals
SXTC
|
$ 3.0 | 4.17 % | $ 2.04 M | Nasdaq Global Select Market |  China |
 |
Rigel Pharmaceuticals
RIGL
|
$ 51.18 | 4.75 % | $ 921 M | Nasdaq Global Select Market | USA |
 |
Celsion Corporation
CLSN
|
- | -6.63 % | $ 13.9 M | Nasdaq Capital Market | USA |
 |
Генетико
GECO
|
- | - | - | MOEX |  Russia |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market | China |
 |
Tenax Therapeutics
TENX
|
$ 1.79 | -2.99 % | $ 70.2 M | Nasdaq Global Select Market | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market |  France |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market | France |
 |
Scholar Rock Holding Corporation
SRRK
|
$ 46.06 | 4.73 % | $ 5.28 B | Nasdaq Global Select Market | USA |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market |  Germany |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
- | 0.74 % | $ 768 M | Nasdaq Capital Market | Israel |
 |
Abcam plc
ABCM
|
- | - | $ 4.9 B | Nasdaq Global Select Market |  Britain |
 |
Rezolute
RZLT
|
$ 3.97 | -1.12 % | $ 413 M | Nasdaq Capital Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | Britain |
 |
Tiziana Life Sciences PLC
TLSA
|
$ 0.64 | -7.06 % | $ 68.3 M | Nasdaq Global Market | Britain |
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market | Germany |
 |
Affimed N.V.
AFMD
|
- | -34.95 % | $ 21.5 M | Nasdaq Global Select Market,SPB | Germany |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
$ 1.71 | -1.16 % | $ 1.15 B | Nasdaq Capital Market | Israel |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
- | -1.58 % | $ 28.1 M | Nasdaq Global Market | China |
 |
Celyad Oncology SA
CYAD
|
- | - | $ 12.5 M | Nasdaq Global Market |  Belgium |
 |
Seer
SEER
|
$ 1.71 | -1.45 % | $ 94.4 M | Nasdaq Global Select Market | USA |
 |
Gracell Biotechnologies
GRCL
|
- | - | $ 3.37 B | Nasdaq Global Select Market | China |
 |
Trevi Therapeutics
TRVI
|
$ 13.98 | 0.87 % | $ 1.88 B | Nasdaq Global Market | USA |
|
Silence Therapeutics plc
SLN
|
$ 19.8 | 0.1 % | $ 2.81 B | Nasdaq Global Select Market | Britain |
 |
Soligenix
SNGX
|
$ 0.35 | -1.15 % | $ 1.82 M | Nasdaq Capital Market | USA |
 |
Spruce Biosciences
SPRB
|
$ 46.23 | 7.99 % | $ 35.4 M | Nasdaq Global Select Market | USA |
 |
Supernus Pharmaceuticals
SUPN
|
$ 28.24 | 0.32 % | $ 1.59 B | Nasdaq Global Select Market,SPB | USA |
 |
Galapagos NV
GLPG
|
- | - | $ 1.83 B | Nasdaq Global Select Market | Belgium |
 |
Savara
SVRA
|
$ 4.66 | -2.0 % | $ 1.04 B | Nasdaq Global Select Market | USA |
 |
Teligent, Inc.
TLGT
|
- | -13.85 % | $ 16.1 M | Nasdaq Global Select Market | USA |
 |
Viela Bio, Inc.
VIE
|
- | - | $ 2.91 B | Nasdaq Global Select Market | USA |
 |
TG Therapeutics
TGTX
|
$ 61.48 | 1.19 % | $ 8.87 B | Nasdaq Capital Market | USA |
 |
VistaGen Therapeutics
VTGN
|
$ 0.19 | 11.9 % | $ 7.23 M | Nasdaq Global Select Market | USA |
 |
Aphria Inc.
APHA
|
- | -0.45 % | $ 4.87 B | Nasdaq Global Select Market |  Canada |
 |
Aerpio Pharmaceuticals, Inc.
ARPO
|
- | -0.90 % | $ 104 M | Nasdaq Capital Market | USA |
 |
Chiasma, Inc.
CHMA
|
- | -6.00 % | $ 238 M | Nasdaq Global Select Market | USA |
 |
Wave Life Sciences Ltd.
WVE
|
$ 3.62 | 1.96 % | $ 611 M | Nasdaq Global Select Market |  Singapore |
|
XBiotech
XBIT
|
$ 1.96 | -1.51 % | $ 59.8 M | Nasdaq Global Select Market | USA |
 |
Adamas Pharmaceuticals, Inc.
ADMS
|
- | - | $ 376 M | Nasdaq Global Market | USA |
 |
Cellect Biotechnology Ltd.
APOP
|
- | 0.38 % | $ 12.9 M | Nasdaq Global Select Market | Israel |
 |
AzurRx BioPharma, Inc.
AZRX
|
- | 2.07 % | $ 34.4 M | Nasdaq Capital Market | USA |
 |
Cerecor Inc.
CERC
|
- | -1.68 % | $ 283 M | Nasdaq Capital Market | USA |